FANTAPPIE', ORNELLA
FANTAPPIE', ORNELLA
Medicina Sperimentale e Clinica
Aldoxorubicin and Temozolomide combination in a xenograft mice model of human glioblastoma.
2018 Da Ros M, Iorio AL, De Gregorio V, Fantappiè O, Laffi G, de Martino M, Pisano C, Genitori L, Sardi I
Bile acid inhibition of p-glycoprotein mediated transport in multidrug resistant cells and rat liver canalicular membrane vesicles
1994 R. MAZZANTI; O. FANTAPPIE'; Y. KAMIMOTO; Z. GATMAITAN; P. GENTILINI; I.M. ARIAS
Breast cancer resistance protein (BCRP) expression and activity in mitochondria of different multiple drug-resistant (MDR) cancer cell lines
2009 Mazzanti, R; Solazzo, M; Fantappie, O; D'Amico, M; Sassoli, C; Tani, A; Cipriani, G; Bogani, C; Pestrin, M; Formigli, L
Chronic viral hepatitis induced by hepatitis C but not hepatitis B virus infection correlates with increased liver angiogenesis
1997 MAZZANTI R; MESSERINI L; MONSACCHI L; BUZZELLI G; A. ZIGNEGO; FOSCHI M; MONTI M; LAFFI G; MORBIDELLI L; FANTAPPIE' O; BARTOLONI SAINT OMER F; ZICHE M.
Conferring drug resistance by MDR1 gene transfection increases susceptibility to irradiation and lipid peroxidation
1996 R. MAZZANTI; O. FANTAPPIE'; P. FABRIZIO; S. PACINI; F. CASAMASSIMA; F. MILANO; M. RUGGIERO; P. RELLI
Cyclooxygenase-2 activation mediates the proangiogenic effect of nitric oxide in colorectal cancer
2004 F. CIANCHI; C. CORTESINI; O. FANTAPPIE'; L. MESSERINI; I. SARDI; F. PERNA; V. FABBRONI; G. PERIGLI; R. MAZZANTI; E. MASINI; N. LASAGNA; A. FELICE
Differential expression proteomics of human colon cancer
2006 R.Mazzanti;M.Solazzo;O.FANTAPPIE';S.Elfering;P.Pantaleo;P.Bechi;F.Cianchi;A.Ettl;C.Giulivi
Down-regulation of HGF/MET autocrine loop induced by celecoxib and mediated by P-gp in MDR-positive human hepatocellular carcinoma cell line
2009 R.Mazzanti; F. Platini; C. Bottini; O Fantappiè; M. Solazzo; L. Tessitore.
Heme oxygenase-1 and the ischemia-reperfusion injury in the rat heart
2003 Masini E; Vannacci A; Marzocca C; Pierpaoli S; Giannini L; FANTAPPIE' O; Mazzanti R; Mannaioni PF.
Hepatocyte Growth Factor and Inducible Nitric Oxide Synthase Are Involved in Multidrug Resistance–Induced Angiogenesis in Hepatocellular Carcinoma Cell Lines
2006 N. LASAGNA; O. FANTAPPIE'; M. SOLAZZO; L. MORBIDELLI; S. MARCHETTI; G. CIPRIANI; M. ZICHE; R. MAZZANTI
ISOLAMENTO E CARATTERIZZAZIONE DI MUTANTI DI AZOSPIRILLUM BRASILENSE ALTERATI NELLA PRODUZIONE DI SIDEROFORI
1989 O. FANTAPPIE'; M. BAZZICALUPO; R. FANI; E. GALLORI; M. POLSINELLI
ISOLATION AND CHARACTERIZATION OF AZOSPIRILLUM BRASILENSE MUTANTS ALTERED IN THE PRODUCTION OF SIDEROPHORES
1990 M. BAZZICALUPO; R. FANI; O. FANTAPPIE'; E. GALLORI; E. MORI; M. POLSINELLI
Lipid peroxidation and cyclooxygenase-2 activity in human hepatocellular carcinoma cell lines with and without multiple drug resistance: correlation with cell growth
2001 Masini, E.; Fantappie, O.; Raimondi, L.; Mannaioni, P. F.; Mazzanti, R.; Fabbroni, V.; Sardi, I.
Mitochondria of a human multidrug-resistant hepatocellular carcinoma cell line constitutively express inducible nitric oxide synthase in the inner membrane
2015 Ornella, Fantappiè; Chiara, Sassoli; Alessia, Tani; Daniele, Nosi; Marchetti, S; Lucia, Formigli; Roberto, Mazzanti
Mitochondrial expression and functional activity of Breast Cancer Resistance Protein in different multiple drug-resistant cell lines
2009 M. Solazzo; O. FANTAPPIE'; M. D'Amico; C. Sassoli; A. Tani; G. Cipriani; C. Bogani; L. Formigli; R. Mazzanti
Mitochondrial localization and functional expression of P glycoprotein in MDR phenotype expressing cell lines
2006 M. Solazzo; O. Fantappiè; N. Lasagna; C. Sassoli; R. Mazzanti
P-glycoprotein mediates celecoxib-induced apoptosis in multiple drug resistant cell lines
2007 FANTAPPIE' O; SOLAZZO M; LASAGNA N; PLATINI F; TESSITORE L; R. MAZZANTI
P-gp localization in mitochondria and its functional characterization in multiple drug-resistant cell lines.
2006 M. Solazzo ;O. FANTAPPIE';N. Lasagna ;C. Sassoli ; D. Nosi ;R. Mazzanti.
Susceptibility to lipid peroxidation of human hepatocellular carcinoma cell lines with different levels of multiple drug resistant phenotype
1995 R. MAZZANTI; O. FANTAPPIE'; P. FABRIZIO; P. RELLI
The endocannabinoid 2-arachidonylglycerol decreases the immunological activation of Guinea pig mast cells: involvement of nitric oxide and eicosanoids.
2004 Vannacci A; Giannini L; Passani MB; Di Felice A; Pierpaoli S; Zagli G; Fantappie' O; Mazzanti R; Masini E; Mannaioni PF